BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29210323)

  • 1. Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis.
    Naidoo A; Ramsuran V; Chirehwa M; Denti P; McIlleron H; Naidoo K; Yende-Zuma N; Singh R; Ngcapu S; Chaudhry M; Pepper MS; Padayatchi N
    Pharmacogenomics; 2018 Jan; 19(1):17-29. PubMed ID: 29210323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis.
    Naidoo A; Chirehwa M; Ramsuran V; McIlleron H; Naidoo K; Yende-Zuma N; Singh R; Ncgapu S; Adamson J; Govender K; Denti P; Padayatchi N
    Pharmacogenomics; 2019 Mar; 20(4):225-240. PubMed ID: 30767706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ABCB1, UGT1A1, and UGT1A9 Genetic Polymorphisms on the Pharmacokinetics of Sitafloxacin Granules in Healthy Subjects.
    Sun LN; Sun GX; Yang YQ; Shen Y; Huang FR; Xie LJ; Cheng J; Zhang HW; Zhang XH; Liu Y; Wang YQ
    Clin Pharmacol Drug Dev; 2021 Jan; 10(1):57-67. PubMed ID: 32687695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of multidrug resistance gene-1 (ABCB1) polymorphisms on the single-dose pharmacokinetics of cloxacillin in healthy adult Chinese men.
    Yin OQ; Tomlinson B; Chow MS
    Clin Ther; 2009 May; 31(5):999-1006. PubMed ID: 19539100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of genetic association between OCT1, ABCB1, and UGT2B7 variants and morphine pharmacokinetics.
    Nielsen LM; Sverrisdóttir E; Stage TB; Feddersen S; Brøsen K; Christrup LL; Drewes AM; Olesen AE
    Eur J Pharm Sci; 2017 Mar; 99():337-342. PubMed ID: 28063968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.
    Staatz CE; Goodman LK; Tett SE
    Clin Pharmacokinet; 2010 Mar; 49(3):141-75. PubMed ID: 20170205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin.
    Gouin-Thibault I; Delavenne X; Blanchard A; Siguret V; Salem JE; Narjoz C; Gaussem P; Beaune P; Funck-Brentano C; Azizi M; Mismetti P; Loriot MA
    J Thromb Haemost; 2017 Feb; 15(2):273-283. PubMed ID: 27893182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the association between paroxetine serum concentration and SERT-occupancy by ABCB1 (P-glycoprotein) polymorphisms in major depressive disorder.
    Simoons M; Mulder H; Appeldoorn JTY; Risselada AJ; Schene AH; van Schaik RHN; van Roon EN; Ruhé EG
    Psychiatr Genet; 2020 Feb; 30(1):19-29. PubMed ID: 31634334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters.
    Milosheska D; Lorber B; Vovk T; Kastelic M; Dolžan V; Grabnar I
    Br J Clin Pharmacol; 2016 Aug; 82(2):399-411. PubMed ID: 27096250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics.
    Zhou Q; Ruan ZR; Yuan H; Xu DH; Zeng S
    Pharmazie; 2013 Feb; 68(2):129-34. PubMed ID: 23469685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of genetic polymorphisms in CYP1A2, UGT1A4, and ABCB1 with autonomic nervous system dysfunction in schizophrenia patients treated with olanzapine.
    Hattori S; Suda A; Miyauchi M; Shiraishi Y; Saeki T; Fukushima T; Fujibayashi M; Tsujita N; Ishii C; Ishii N; Moritani T; Saigusa Y; Kishida I
    BMC Psychiatry; 2020 Feb; 20(1):72. PubMed ID: 32070304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3A5, CYP2C19 and ABCB1.
    Yoo HD; Cho HY; Lee YB
    Br J Clin Pharmacol; 2010 Jan; 69(1):27-37. PubMed ID: 20078610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan.
    Salvador-Martín S; García-González X; García MI; Blanco C; García-Alfonso P; Robles L; Grávalos C; Pachón V; Longo F; Martínez V; Sanjurjo-Sáez M; López-Fernández LA
    Pharmacol Res; 2018 Oct; 136():133-139. PubMed ID: 30213564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute rejection in kidney transplantation and the evaluation of associated polymorphisms (SNPs): the importance of sample size.
    Neri A; Scalzotto E; Corradi V; Caprara C; Salin A; Cannone M; De Cal M; Romano G; Tulissi P; Cussigh AR; Montanaro D; Frigo A; Giavarina D; Chiaramonte S; Ronco C
    Diagnosis (Berl); 2019 Aug; 6(3):287-295. PubMed ID: 30901313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients.
    Chew SC; Singh O; Chen X; Ramasamy RD; Kulkarni T; Lee EJ; Tan EH; Lim WT; Chowbay B
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1471-8. PubMed ID: 21468756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations.
    Ngaimisi E; Habtewold A; Minzi O; Makonnen E; Mugusi S; Amogne W; Yimer G; Riedel KD; Janabi M; Aderaye G; Mugusi F; Bertilsson L; Aklillu E; Burhenne J
    PLoS One; 2013; 8(7):e67946. PubMed ID: 23861838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia.
    Hattori S; Suda A; Kishida I; Miyauchi M; Shiraishi Y; Fujibayashi M; Tsujita N; Ishii C; Ishii N; Moritani T; Taguri M; Hirayasu Y
    BMC Psychiatry; 2018 Jul; 18(1):231. PubMed ID: 30016952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis.
    Shi XJ; Geng F; Jiao Z; Cui XY; Qiu XY; Zhong MK
    J Clin Pharm Ther; 2011 Oct; 36(5):614-24. PubMed ID: 21916909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients.
    Baietto L; D'Avolio A; Cusato J; Pace S; Calcagno A; Motta I; Corcione S; Di Perri G; De Rosa FG
    J Antimicrob Chemother; 2015 Jan; 70(1):307-8. PubMed ID: 25239468
    [No Abstract]   [Full Text] [Related]  

  • 20. Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.
    Tanabe Y; Shimizu C; Hamada A; Hashimoto K; Ikeda K; Nishizawa D; Hasegawa J; Shimomura A; Ozaki Y; Tamura N; Yamamoto H; Yunokawa M; Yonemori K; Takano T; Kawabata H; Tamura K; Fujiwara Y
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1179-1186. PubMed ID: 28447211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.